Genomic profiling of C/EBPbeta2 transformed mammary epithelial cells: A role for nuclear interleukin-1beta

Cancer Biology and Therapy

Volumn 10, Issue 5, 2010, Pages 509-519

  Russell, Alisha ^a   Boone, Braden ^a   Jiang, Aixiang ^a   Sealy, Linda ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; C EBPbeta; Dual function cytokine; Interleukin 1beta

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 1BETA;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CHROMATIN; CHROMOSOME; GENE EXPRESSION PROFILING; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEUS ACCUMBENS; PHENOTYPE; PROTEIN EXPRESSION; TUMOR GENE;

BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-1BETA; MAMMARY GLANDS, HUMAN; PROTEIN PRECURSORS; RECEPTORS, INTERLEUKIN-1 TYPE II; SIGNAL TRANSDUCTION;

EID: 77957161834     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.5.12725     Document Type: Article

References (38)

1. Apte R, Voronov E. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol Rev 2008; 222:222-41.
2. Bunt SB, Sinha P, Clements V, Leips J, Ostrand-Rosenberg S. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J of Immunol 2006; 176:284-90.
3. Jin L, Yuan RQ, Fuchs A, Yao Y, Joseph A, Schwall R, et al. Expression of interleukin-1beta in human breast carcinoma. Cancer 1997; 80:421-34.
4. Pantschenko AG, Pushkar I, Anderson KH, Wang Y, Miller LJ, Kurtzman SH, et al. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int J Oncol 2003; 23:269-84.
5. Kurtzman SH, Anderson KH, Wang Y, Miller LJ, Renna M, Stankus M, et al. Cytokines in human breast cancer: IL-1alpha and IL-1beta expression. Oncol Rep 1999; 6:65-70.
6. Robinson G, Johnson P, Hennighausen L, Sterneck E. The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes and Dev 1998; 12:1907-16. (Pubitemid 28304342)
7. Seagroves T, Krnacik S, Raught B, Gay J, Burgess-Beusse B, Darlingtion G, Rosen J. C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobulalveolar proliferation and fuctional differentiation in the mouse mammary gland. Genes and Dev 1998; 12:1917-28.
8. Zhu S, Yoon K, Sterneck E, Johnson PF, Smart RC. CCAAT/enhancer binding protein-beta is a mediator of keratinocytes survival and skin tumorigenesis involving oncogenic Ras signaling. PNAS 2002; 99:207-12.
9. Milde-Langosch K, Loning T, Bamberger A. Expression go the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell cycle regulatory proteins. Breast Cancer Res Treat 2003; 79:175-85.
10. Descombes P, Schibler U. A liver enriched transcriptional activator protein, LAP and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 1991; 3:569-79. (Pubitemid 121001471)
11. Kowenz-Leutz E, Leutz A. A C/EBPbeta isoform recruits the SWI/SNF complex to activate myloid genes. Mol Cell 1999; 4:735-43.
12. Eaton E, Hanlon M, Bundy L, Sealy L. Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells. J Cell Physiol 2001; 189:91-105.
13. Eaton E, Sealy L. Modification of CCAAT/Enhancer binding protein beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. J Biol Chem 2003; 278:33416-21.
14. Bundy L, Sealy L. CCAAT/enhancer binding protein beta (C/EBPb)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 2003; 22:869-83. (Pubitemid 36255823)
15. Bundy L, Wells S, Sealy L. C/EBPbeta2 confers EGF-independent growth and disrupts the normal acinar architecture of human mammary epithelial cells. Mol Cancer 2005; 4:43-60.
16. Liang M, Zhang Y, McDevit D, Marecki S, Nikolajczrk B. The Interleukin-1beta Gene is Transcribed from a Poised Promoter Architecture in Monocytes. J Biol Chem 2006; 281:9227-37.
17. Arend W, Malyak M, Guthridge C, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998; 16:27-55. (Pubitemid 28183358)
18. Maier JA, Statuto M, Ragnotti G. Endogenous interleukin 1alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol Cell Biol 1994; 14:1845-51.
19. Buryskova M, Popisek M, Grothey A, Simmer T, Burysek L. Intracellular Interleukin-1alpha Functionally Interacts with Histone Acetyltransferase Complexes. J Biol Chem 2004; 279:2017-4026.
20. Hu B, Wang S, Zhang Y, Feghali CA, Dingman JR, Wright TM, et al. A nuclear target for interleukin-1-alpha: interaction with the growth suppressor necdin modulates proliferation and collegen expression. PNAS USA 2003; 100:10008-13. (Pubitemid 37087059)
21. Cato L, Stott K, Watson M, Thomas JO. The interaction of HMGB1 and linker histones occurs through their acidic and basic tails. J Mol Biol 2008; 384:1262-72.
22. Roussel L, Monique E, Cayrol C, Girard J. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through H2A-H2B acidic pocket. EMBO Reports 2008; 9:1006-12.
23. Chaing A, Massague J. Molecular Origins of Cancer Molecular Basis of Metastasis. N Engl J Med 2008; 359:2814-23.
24. Werenskiold AK, Prechtel D, Harbeck N, Hofler H. Tumor-associated overexpression of the soluble T1-S receptor in lymph node-negative breast cancer. Diagn Mol Pathol 2000; 9:26-34. (Pubitemid 30131959)
25. Barrows G, Kreutzer DL. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int J Oncol 2003; 23:269-84.
26. Grenfell S, Smithers N, Witham S, Shaw A, Graber P, Solari R. Analysis of mutations in the putative nuclear localization sequence of interleukin-1beta. Biochem J 1991; 280:111-6.
27. Mosley B, Urdal D, Prickett KS, Larsen A, Cosman D, Conlon PJ, et al. The interleukin-1 receptor binds the human interleukin-1alpha precursor but not the intereleukin-1beta precursor. J Biol Chem 1987; 262:2941-4. (Pubitemid 17127537)
28. Luheshi N, Rothwell N, Brough D. The dynamics and mechanisms of interleukin-1alpha and Beta nuclear import. Traffic 2009; 10:16-25.
29. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 2009; Epub ahead of print.
30. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009; 27:229-65.
31. Conway KE, McConnell B, Bowring C, Donald C, Warren S, Vertino P, et al. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res 2000; 60:6236-42.
32. Stone AR, Bobo W, Brat DJ, Devi NS, Van Meir EG, Vertino PM. Aberrant methylation and downregulation of TMS1/ASC in human glioblastoma. Am J Pathol 2004; 165:1151-61. (Pubitemid 39297722)
33. Teresawa K, Sagae S, Toyota M, Tsukada K, Ogi K, Satoh A, et al. Epigenetic inactivation of TMS1/ASC in ovarian cancer. Clin Cancer Res 2004; 10:2000-6. (Pubitemid 38375559)
34. Guan X, Sagara J, Yokoyama T, Koganehira Y, Oguchi M, Saida T, Taniquchi S. ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma. Int J Cancer 2003; 107:202-8. (Pubitemid 37152898)
35. Virmani A, Rathi A, Sugio K, Sathanaravana UG, Toyooka S, Kischel FC, et al. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Int J Cancer 2003; 106:198-204. (Pubitemid 36835171)
36. Yokoyama T, Sagara J, Guan X, Masumoto J, Takeoka M, Komiyama, et al. Methylation of ASC/TMS1, a proapoptotic gene responsible for activating procaspase-1, in human colorectal cancer. Cancer Lett 2003; 202:101-8.
37. Thomas P, Kejariwal A, Guo N, Mi H, Campbell M, Muruganujan A, Lazareva-Ulitsky B. Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucl Acids Res 2006; 34: 645-50.
38. Backes C, Keller A, Kuentzer J, Kneissl B, Comtesse N, Elnakady YA, et al. GeneTrail - advanced gene set enrichment analysis. Nucleic Acids Res 2007; 35:186-92.